{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:32:56Z","timestamp":1786980776989,"version":"build-2736575974"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T00:00:00Z","timestamp":1694044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T00:00:00Z","timestamp":1694044800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004329","name":"Javna Agencija za Raziskovalno Dejavnost RS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To determine whether the absence of post-treatment changes in the negative sentinel lymph nodes (SLN) in the neoadjuvant setting for biopsy-proven cN\u2009+\u2009disease results in an increased regional recurrence (RR) rate in patients after SLN biopsy (SLNB) only.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Breast cancer patients with biopsy-proven cN\u2009+\u2009disease who converted to node-negative disease after neoadjuvant systemic treatment (NAST) and underwent SLNB only were included. Retrospective analysis was performed for patients diagnosed between 2008 and 2021. Pathohistological specimens were reviewed for the presence of post-treatment changes in the SLNs. Patients with negative SLNs (ypN0) were divided into two groups: (i) with post-treatment changes, (ii) without post-treatment changes. Patients\u2019 characteristics were compared between groups. Crude RR rates were compared using the log-rank test. Recurrence-free (RFS) and overall survival (OS) for the entire cohort were calculated using Kaplan\u2013Meier.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of 437 patients with cN\u2009+\u2009disease, 95 underwent SLNB only. 82 were ypN0, 57 with post-treatment changes (group 1), 25 without post-treatment changes (group 2). During the median follow-up of 37\u00a0months (range 6\u2013148), 1 isolated regional recurrence occurred in group 2 (RR rate 0% for group 1 vs. 4% for group 2,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.149). There were no differences in 3-year RFS and OS between groups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Absent post-treatment changes in negative SLNs for biopsy-proven cN\u2009+\u2009disease that covert to node-negative after NAST did not result in increased regional recurrence rates in our cohort. Multidisciplinary input is essential to determine whether additional treatment is needed in these patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10549-023-07084-x","type":"journal-article","created":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T14:02:05Z","timestamp":1694095325000},"page":"443-450","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Absence of post-treatment changes in sentinel lymph nodes does not translate into increased regional recurrence rate in initially node-positive breast cancer patients"],"prefix":"10.1007","volume":"202","author":[{"given":"Nina","family":"Pislar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gorana","family":"Gasljevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivica","family":"Ratosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Kovac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janez","family":"Zgajnar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0559-3813","authenticated-orcid":false,"given":"Andraz","family":"Perhavec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,7]]},"reference":[{"issue":"11","key":"7084_CR1","doi-asserted-by":"publisher","first-page":"3467","DOI":"10.1245\/s10434-016-5246-8","volume":"23","author":"A Mamtani","year":"2016","unstructured":"Mamtani A, Barrio AV, King TA et al (2016) How often does neoadjuvant chemotherapy avoid axillary dissection in patients with histologically confirmed nodal metastases? results of a prospective study. Ann Surg Oncol 23(11):3467\u20133474","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"7084_CR2","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/S1470-2045(13)70166-9","volume":"14","author":"T Kuehn","year":"2013","unstructured":"Kuehn T, Bauerfeind I, Fehm T et al (2013) Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study. Lancet Oncol 14(7):609\u2013618","journal-title":"Lancet Oncol"},{"issue":"3","key":"7084_CR3","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1200\/JCO.2014.55.7827","volume":"33","author":"JF Boileau","year":"2015","unstructured":"Boileau JF, Poirier B, Basik M et al (2015) Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: The SN FNAC study. J Clin Oncol 33(3):258\u2013263","journal-title":"J Clin Oncol"},{"issue":"14","key":"7084_CR4","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1001\/jama.2013.278932","volume":"310","author":"JC Boughey","year":"2013","unstructured":"Boughey JC, Suman VJ, Mittendorf EA et al (2013) Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: The ACOSOG Z1071 (alliance) clinical trial. JAMA 310(14):1455\u20131461","journal-title":"JAMA"},{"issue":"5\u20136","key":"7084_CR5","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s10585-018-9902-1","volume":"35","author":"SD Nathanson","year":"2018","unstructured":"Nathanson SD, Krag D, Kuerer HM et al (2018) Breast cancer metastasis through the lympho-vascular system. Clin Exp Metastasis 35(5\u20136):443\u2013454","journal-title":"Clin Exp Metastasis"},{"issue":"7","key":"7084_CR6","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1245\/ASO.2003.03.081","volume":"10","author":"LA Newman","year":"2003","unstructured":"Newman LA, Pernick NL, Adsay V et al (2003) Histopathologic evidence of tumor regression in the axillary lymph nodes of patients treated with preoperative chemotherapy correlates with breast cancer outcome. Ann Surg Oncol 10(7):734\u2013739","journal-title":"Ann Surg Oncol"},{"issue":"13","key":"7084_CR7","doi-asserted-by":"publisher","first-page":"4381","DOI":"10.1245\/s10434-019-07915-6","volume":"26","author":"A Glaeser","year":"2019","unstructured":"Glaeser A, Sinn HP, Garcia-Etienne C et al (2019) Heterogeneous responses of axillary lymph node metastases to neoadjuvant chemotherapy are common and depend on breast cancer subtype. Ann Surg Oncol 26(13):4381\u20134389","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"7084_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.surge.2020.01.009","volume":"19","author":"B Riogi","year":"2021","unstructured":"Riogi B, Sripadam R, Barker D et al (2021) Management of the axilla following neoadjuvant chemotherapy for breast cancer- a change in practice. Surgeon 19(1):1\u20137","journal-title":"Surgeon"},{"issue":"5","key":"7084_CR9","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1007\/s00330-004-2545-4","volume":"15","author":"M Podkrajsek","year":"2005","unstructured":"Podkrajsek M, Music MM, Kadivec M et al (2005) Role of ultrasound in the preoperative staging of patients with breast cancer. Eur Radiol 15(5):1044\u20131050","journal-title":"Eur Radiol"},{"issue":"4","key":"7084_CR10","doi-asserted-by":"publisher","first-page":"e597","DOI":"10.1016\/j.clbc.2021.12.013","volume":"22","author":"V Hadalin","year":"2022","unstructured":"Hadalin V, Pislar N, Borstnar S et al (2022) Intraoperative touch imprint cytology in breast cancer patients after neoadjuvant chemotherapy. Clin Breast Cancer 22(4):e597-603","journal-title":"Clin Breast Cancer"},{"issue":"12","key":"7084_CR11","doi-asserted-by":"publisher","first-page":"4795","DOI":"10.1245\/s10434-020-08900-0","volume":"27","author":"MA Piltin","year":"2020","unstructured":"Piltin MA, Hoskin TL, Day CN, Davis J, Boughey JC (2020) Oncologic Outcomes of sentinel lymph node surgery after neoadjuvant chemotherapy for node-positive breast cancer. Ann Surg Oncol 27(12):4795\u20134801","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"7084_CR12","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.1245\/s10434-018-6637-9","volume":"25","author":"TT Nguyen","year":"2018","unstructured":"Nguyen TT, Hoskin TL et al (2018) Decreasing use of axillary dissection in node-positive breast cancer patients treated with neoadjuvant chemotherapy. Ann Surg Oncol 25(9):2596\u20132602","journal-title":"Ann Surg Oncol"},{"key":"7084_CR13","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.breast.2021.07.015","volume":"59","author":"S Cao","year":"2021","unstructured":"Cao S, Liu X, Cui J et al (2021) Feasibility and reliability of sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer patients with positive axillary nodes at initial diagnosis: an up-to date meta-analysis of 3,578 patients. Breast 59:256\u2013269","journal-title":"Breast"},{"issue":"12","key":"7084_CR14","doi-asserted-by":"publisher","first-page":"2878","DOI":"10.1002\/cncr.25066","volume":"116","author":"AS Brown","year":"2010","unstructured":"Brown AS, Hunt KK, Shen J et al (2010) Histologic changes associated with false-negative sentinel lymph nodes after preoperative chemotherapy in patients with confirmed lymph node-positive breast cancer before treatment. Cancer 116(12):2878\u20132883","journal-title":"Cancer"},{"issue":"11","key":"7084_CR15","doi-asserted-by":"publisher","first-page":"3475","DOI":"10.1245\/s10434-016-5463-1","volume":"23","author":"AV Barrio","year":"2016","unstructured":"Barrio AV, Mamtani A, Edelweiss M et al (2016) How often is treatment effect identified in axillary nodes with a pathologic complete response after neoadjuvant chemotherapy? Ann Surg Oncol 23(11):3475\u20133480","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"7084_CR16","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1097\/SLA.0000000000001375","volume":"263","author":"JC Boughey","year":"2016","unstructured":"Boughey JC, Ballman KV, Le-Petross HT et al (2016) Identification and resection of clipped node decreases the false-negative rate of sentinel lymph node surgery in patients presenting with node-positive breast cancer (T0\u2013T4, N1\u2013N2) Who receive neoadjuvant chemotherapy: Results from ACO SOG Z107 1 (Alliance). Ann Surg 263(4):802\u2013807","journal-title":"Ann Surg"},{"issue":"12","key":"7084_CR17","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1001\/jamaoncol.2021.4394","volume":"7","author":"AV Barrio","year":"2021","unstructured":"Barrio AV, Montagna G, Mamtani A et al (2021) Nodal recurrence in patients with node-positive breast cancer treated with sentinel node biopsy alone after neoadjuvant chemotherapy - a rare event. JAMA Oncol 7(12):1851\u20131855","journal-title":"JAMA Oncol"},{"issue":"4","key":"7084_CR18","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.ejso.2020.10.014","volume":"47","author":"S Kahler-Ribeiro-Fontana","year":"2021","unstructured":"Kahler-Ribeiro-Fontana S, Pagan E, Magnoni F et al (2021) Long-term standard sentinel node biopsy after neoadjuvant treatment in breast cancer: a single institution ten-year follow-up. Eur J Surg Oncol 47(4):804\u2013812","journal-title":"Eur J Surg Oncol"},{"issue":"5","key":"7084_CR19","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1245\/s10434-020-09211-0","volume":"28","author":"SM Wong","year":"2021","unstructured":"Wong SM, Basik M, Florianova L et al (2021) Oncologic safety of sentinel lymph node biopsy alone after neoadjuvant chemotherapy for breast cancer. Ann Surg Oncol 28(5):2621\u20132629","journal-title":"Ann Surg Oncol"},{"key":"7084_CR20","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/4549033","author":"IC Tercan","year":"2023","unstructured":"Tercan IC, Zengel B, Ozdemir O et al (2023) The oncologic safety of sentinel lymph node biopsy in patients with node-positive breast cancer with complete response to neoadjuvant chemotherapy: a single-center experience. Breast J. https:\/\/doi.org\/10.1155\/2023\/4549033","journal-title":"Breast J"},{"issue":"1","key":"7084_CR21","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s10549-017-4157-0","volume":"163","author":"TJA van Nijnatten","year":"2017","unstructured":"van Nijnatten TJA, Simons JM, Moossdorff M et al (2017) Prognosis of residual axillary disease after neoadjuvant chemotherapy in clinically node-positive breast cancer patients: isolated tumor cells and micrometastases carry a better prognosis than macrometastases. Breast Cancer Res Treat 163(1):159\u2013166","journal-title":"Breast Cancer Res Treat"},{"issue":"11","key":"7084_CR22","doi-asserted-by":"publisher","first-page":"3502","DOI":"10.1245\/s10434-019-07517-2","volume":"26","author":"SM Wong","year":"2019","unstructured":"Wong SM, Almana N, Choi J et al (2019) Prognostic significance of residual axillary nodal micrometastases and isolated tumor cells after neoadjuvant chemotherapy for breast cancer. Ann Surg Oncol 26(11):3502\u20133509","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"7084_CR23","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1001\/jama.2017.11470","volume":"318","author":"AE Giuliano","year":"2017","unstructured":"Giuliano AE, Ballman KV, McCall L et al (2017) Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (Alliance) randomized clinical trial. JAMA 318(10):918\u2013926","journal-title":"JAMA"},{"issue":"3","key":"7084_CR24","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.ejso.2015.11.019","volume":"42","author":"V Galimberti","year":"2016","unstructured":"Galimberti V, Ribeiro Fontana SK, Maisonneuve P et al (2016) Sentinel node biopsy after neoadjuvant treatment in breast cancer: five-year follow-up of patients with clinically node-negative or node-positive disease before treatment. Eur J Surg Oncol 42(3):361\u2013368","journal-title":"Eur J Surg Oncol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-023-07084-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-023-07084-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-023-07084-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T07:11:03Z","timestamp":1696921863000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-023-07084-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,7]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["7084"],"URL":"https:\/\/doi.org\/10.1007\/s10549-023-07084-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2967377\/v1","asserted-by":"object"}]},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,7]]},"assertion":[{"value":"26 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}